Drug Shortage Report for SANDOZ LOSARTAN HCT DS
| Report ID | 236048 |
| Drug Identification Number | 02313383 |
| Brand name | SANDOZ LOSARTAN HCT DS |
| Common or Proper name | LOSARTAN HCT DS |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM |
| Strength(s) | 25MG 100MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100FCTBO |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-08-27 |
| Estimated end date | 2024-12-13 |
| Actual end date | 2024-12-16 |
| Shortage status | Resolved |
| Updated date | 2024-12-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v19 | 2024-12-17 | English | Compare |
| v18 | 2024-12-16 | French | Compare |
| v17 | 2024-12-16 | English | Compare |
| v16 | 2024-12-02 | French | Compare |
| v15 | 2024-12-02 | English | Compare |
| v14 | 2024-11-04 | French | Compare |
| v13 | 2024-11-04 | English | Compare |
| v12 | 2024-11-04 | French | Compare |
| v11 | 2024-11-04 | English | Compare |
| v10 | 2024-10-21 | French | Compare |
| v9 | 2024-10-21 | English | Compare |
| v8 | 2024-09-09 | French | Compare |
| v7 | 2024-09-09 | English | Compare |
| v6 | 2024-08-28 | English | Compare |
| v5 | 2024-08-27 | French | Compare |
| v4 | 2024-08-27 | English | Compare |
| v3 | 2024-08-27 | French | Compare |
| v2 | 2024-08-27 | English | Compare |
| v1 | 2024-08-27 | English | Compare |
Showing 1 to 19 of 19